These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6048200)

  • 1. [Absence of a relation between sensitivity to interferon, interferon production and virulence of "cold" and "warm" mutants of vaccinia virus].
    Lab M; Kirn A
    Ann Inst Pasteur (Paris); 1967 Sep; 113(3):341-50. PubMed ID: 6048200
    [No Abstract]   [Full Text] [Related]  

  • 2. Temperature mutants and recombinants of vaccinia virus. I. Genetic characteristics of temperature mutants.
    Fidziańska E
    Acta Virol; 1972 Jul; 16(4):291-7. PubMed ID: 4403170
    [No Abstract]   [Full Text] [Related]  

  • 3. Study on experimental vaccinia virus infection in mice with special reference to host defence mechanisms.
    Prasad CB; Hedström KG
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):97-111. PubMed ID: 4377639
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relations between rectal temperature and skin temperature in animals and the dermo-virulence of some "cold" and "warm" mutants of vaccinia virus].
    Kirn A; Lab M; Dammron A
    Ann Inst Pasteur (Paris); 1967 Jan; 112(1):113-6. PubMed ID: 6031419
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interferon].
    Jungwirth C; Horak I; Bodo G
    Zentralbl Bakteriol Orig; 1970; 212(2):370-4. PubMed ID: 5462796
    [No Abstract]   [Full Text] [Related]  

  • 6. [New cold variant of Coxsackie virus B5. 3. Protective capacity and capacity for inducing interferon].
    Gevaudan P; Charrel J; Pieroni G; Gevaudan MJ
    C R Seances Soc Biol Fil; 1970; 164(8):1805-8. PubMed ID: 4253209
    [No Abstract]   [Full Text] [Related]  

  • 7. [The relationship between individual interferon production and the skin reaction of rabbits to vaccinia virus].
    Bektemorov TA; Parushina AE
    Vopr Virusol; 1971; 16(4):466-8. PubMed ID: 5137547
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of colchicine on viral interference and interferon formation.
    Solovyov VD; Mentkevich LM
    Acta Virol; 1965 Jul; 9(4):308-12. PubMed ID: 4379488
    [No Abstract]   [Full Text] [Related]  

  • 9. Evasion of innate immunity by vaccinia virus.
    Haga IR; Bowie AG
    Parasitology; 2005; 130 Suppl():S11-25. PubMed ID: 16281988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor.
    Dénes B; Gridley DS; Fodor N; Takátsy Z; Timiryasova TM; Fodor I
    J Gene Med; 2006 Jul; 8(7):814-23. PubMed ID: 16634110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal relationship of interferon production and resistance to experimentally induced virus infection.
    Ash RJ; Bubel HC
    J Infect Dis; 1966 Feb; 116(1):1-7. PubMed ID: 5908851
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the production of interferon in tissue culture infected by vaccinia virus].
    Mazur B
    Med Dosw; 1966; 34():59-87. PubMed ID: 4287721
    [No Abstract]   [Full Text] [Related]  

  • 13. Protection of rabbits against local vaccinia virus infection by Brucella abortus and polyacrylic acid in the absence of systemic interferon production.
    De Clercq E; De Somer P
    Infect Immun; 1973 Oct; 8(4):669-73. PubMed ID: 4355140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response.
    Brandt T; Heck MC; Vijaysri S; Jentarra GM; Cameron JM; Jacobs BL
    Virology; 2005 Mar; 333(2):263-70. PubMed ID: 15721360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interferon-inducing capability of vaccinia virus strains of differing pathogenicity].
    Bektemirov TA; Shenkman LS; Marennikova SS
    Vopr Virusol; 1971; 16(5):555-60. PubMed ID: 5129929
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of supraoptimal temperatures on the development of vaccinia virus in cell cultures. 3. Cytologic study of the synthesis of viral antigens].
    Braunwald J; Kirn A
    Ann Inst Pasteur (Paris); 1967 Apr; 112(4):495-503. PubMed ID: 6077390
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of certain factors on interferon production in monolayer chick embryo tissue culture].
    Bektemirov TA; Gumennik AE
    Vopr Virusol; 1965; 10(6):689-93. PubMed ID: 5896232
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon production and sensitivity in passaged human embryonic fibroblasts.
    Dowjat K; Plachcińska J; Zakrzewski K
    Arch Immunol Ther Exp (Warsz); 1974; 22(6):725-33. PubMed ID: 4451440
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes.
    Dai K; Liu Y; Liu M; Xu J; Huang W; Huang X; Liu L; Wan Y; Hao Y; Shao Y
    Vaccine; 2008 Sep; 26(39):5062-71. PubMed ID: 18573290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Production of the virus inhibiting factor by peritoneal phagocytes of the uninoculated rabbit].
    Nagano Y; Kojima Y; Arakawa J; Kanashiro RS
    Jpn J Exp Med; 1966 Oct; 36(5):481-7. PubMed ID: 5298296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.